Figure 1From: Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer PAI-1 mRNA expression in relapsed and non-relapsed breast cancer patients as measured by quantitative RT-PCR. Differential PAI-1 gene expression between relapsed (n = 30) and non-relapsed (n = 57) patients with MFS as end-point (Mann-Whitney test; p < 0.0001).Back to article page